2m 2m 2m 2m 2m 2m 2m
BIOXCEL THERPTC (BTAI)
NASDAQ
$0.85+$0.04 (+4.83%)
Price as of Aug 03, 2026 12:44 PM EDT- $24.9MMarket Cap
- -41.02%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
BIOXCEL THERPTC (BTAI)
$0.85+$0.04 (+4.83%)
BTAI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.81 | ||
Change | +$0.02 (+1.92%) | ||
Open | $0.79 | ||
High | $0.84 | ||
Low | $0.78 | ||
Previous Close | $0.79 | ||
Volume | 499,492 | ||
30-Day Average Volume | 1,359,726 | ||
1-Week Change | -4.66% | ||
1-Month Change | -42.70% | ||
1-Year Change | -41.02% | ||
3-Year Change | -99.45% | ||
5-Year Change | -99.80% | ||
Fundamentals | |||
Shares Outstanding | 30.9M | ||
Total Assets | $34.0M | ||
Market Cap | $24.9M | ||
Enterprise Value | $108.1M | ||
Period: QTR TTM FY | |||
Revenue | $206,000.00 | ||
Net Income | -$12.7M | ||
Free Cash Flow | -$11.8M | ||
EBIT | -$9.0M | ||
EBITDA | -$8.9M | ||
Net Working Capital | -$21.1M | ||
EPS | -$0.54 | ||
Enterprise Value/EBITDA | -12 | ||
Enterprise Value/Revenue | 525 | ||
P/B | -0 | ||
P/E | -1 | ||
PEG | -0 | ||
Price/Free Cash Flow | -2 | ||
Price/Operating Cash Flow | -2 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 16 | ||
Last Split Date | 02/10/2025 | ||
Earnings & Revenue